Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Jackson Financial
JXN
$9.1B
| $12.4M | ﹤0.01% |
116,185
-3,512
| -3% | -$349K |
|
1527
Bank OZK
OZK
$5.7B
| $12.4M | ﹤0.01% |
269,240
+133,550
| +98% | +$6.25M |
|
1528
CALL
Cameco
CCJ
$42.6B
| $12.4M | ﹤0.01% |
135,000
-330,600
| -71% | -$29.8M |
|
1529
PUT
Centene
CNC
$32.6B
| $12.3M | ﹤0.01% |
300,000
-593,700
| -66% | -$22.2M |
|
1530
NNN REIT
NNN
$8.87B
| $12.3M | ﹤0.01% |
310,380
+81,801
| +36% | +$3.35M |
|
1531
Petrobras Class A
PBR.A
$104B
| $12.3M | ﹤0.01% |
1,090,567
-62,868
| -5% | -$726K |
|
1532
Omega Healthcare
OHI
$13.9B
| $12.3M | ﹤0.01% |
276,742
-56,617
| -17% | -$2.44M |
|
1533
Celcuity
CELC
$4.22B
| $12.3M | ﹤0.01% |
122,854
+71,053
| +137% | +$5.84M |
|
|
HUT
1534
CALL
Hut 8
HUT
$10.2B
| $12.2M | ﹤0.01% |
266,600
+202,100
| +313% | +$8.91M |
|
1535
ODDITY Tech
ODD
$615M
| $12.2M | ﹤0.01% |
304,506
+249,374
| +452% | +$11.3M |
|
1536
Rigetti Computing
RGTI
$6.21B
| $12.2M | ﹤0.01% |
552,257
-62,807
| -10% | -$2.05M |
|
|
BULL
1537
CALL
Webull Corp
BULL
$4.23B
| $12.2M | ﹤0.01% |
1,574,200
| – | – |
|
1538
CALL
Marathon Digital Holdings
MARA
$3.56B
| $12.2M | ﹤0.01% |
1,361,100
+711,900
| +110% | +$10.5M |
|
1539
Tradeweb Markets
TW
$22.3B
| $12.2M | ﹤0.01% |
113,650
-11,897
| -9% | -$1.28M |
|
1540
TTM Technologies
TTMI
$14.6B
| $12.2M | ﹤0.01% |
176,526
+34,636
| +24% | +$2.26M |
|
1541
Capri Holdings
CPRI
$1.77B
| $12.2M | ﹤0.01% |
497,986
+203,855
| +69% | +$4.71M |
|
1542
PUT
Rio Tinto
RIO
$160B
| $12.1M | ﹤0.01% |
150,900
+900
| +0.6% | +$64.8K |
|
1543
SiTime
SITM
$20.7B
| $12.1M | ﹤0.01% |
34,149
-2,960
| -8% | -$926K |
|
1544
Option Care Health
OPCH
$3.61B
| $12.1M | ﹤0.01% |
378,384
-48,021
| -11% | -$1.41M |
|
1545
COPT Defense Properties
CDP
$4.23B
| $12M | ﹤0.01% |
433,124
+158,400
| +58% | +$4.57M |
|
1546
Group 1 Automotive
GPI
$3.14B
| $12M | ﹤0.01% |
30,613
-6,868
| -18% | -$2.82M |
|
1547
Yeti Holdings
YETI
$3.44B
| $12M | ﹤0.01% |
272,188
+199,670
| +275% | +$7.68M |
|
1548
Cavco Industries
CVCO
$4.67B
| $12M | ﹤0.01% |
20,343
+4,183
| +26% | +$2.37M |
|
1549
Texas Roadhouse
TXRH
$13.6B
| $12M | ﹤0.01% |
72,288
-4,528
| -6% | -$766K |
|
1550
Insight Enterprises
NSIT
$4.6B
| $12M | ﹤0.01% |
147,156
+93,858
| +176% | +$8.8M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.